SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/30/12 Weikang Bio-Tech Group Co., Inc. 10-K 12/31/11 44:2.3M Toppan Merrill/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 474K 2: EX-10.12 Material Contract HTML 15K 3: EX-14.1 Code of Ethics HTML 26K 4: EX-23.1 Consent of Experts or Counsel HTML 14K 5: EX-23.2 Consent of Experts or Counsel HTML 13K 6: EX-31.1 Certification -- §302 - SOA'02 HTML 19K 7: EX-31.2 Certification -- §302 - SOA'02 HTML 19K 8: EX-32.1 Certification -- §906 - SOA'02 HTML 15K 9: EX-32.2 Certification -- §906 - SOA'02 HTML 15K 28: R1 Document and Entity Information HTML 45K 21: R2 Consolidated Balance Sheets HTML 128K 26: R3 Consolidated Balance Sheets (Parenthetical) HTML 25K 30: R4 Consolidated Statements of Income and HTML 99K Comprehensive Income 41: R5 Consolidated Statements of Cash Flows HTML 111K 22: R6 Consolidated Statements of Stockholders' Equity HTML 64K 25: R7 Organization and Description of Business HTML 26K 20: R8 Summary of Significant Accounting Policies HTML 65K 18: R9 Accounts Receivable HTML 22K 42: R10 Advances to Suppliers and Other Receivables HTML 17K 32: R11 Inventory HTML 20K 31: R12 Property and Equipment, net HTML 23K 36: R13 Construction in Progress HTML 15K 37: R14 Intangible Assets HTML 21K 35: R15 Related Party Transactions HTML 20K 38: R16 Major Customers and Vendors HTML 15K 27: R17 Unearned Revenue HTML 18K 29: R18 Taxes Payable HTML 17K 34: R19 Other Payables and Accrued Expenses HTML 18K 44: R20 Deferred Tax Asset (Liability) HTML 19K 39: R21 Income Taxes HTML 26K 23: R22 Stockholders' Equity HTML 62K 33: R23 Statutory Reserves HTML 18K 24: R24 Contingencies HTML 16K 16: R25 Goodwill HTML 16K 40: R26 Subsequent Event HTML 16K 43: XML IDEA XML File -- Filing Summary XML 53K 19: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 212K 10: EX-101.INS XBRL Instance -- wkbt-20111231 XML 314K 12: EX-101.CAL XBRL Calculations -- wkbt-20111231_cal XML 105K 13: EX-101.DEF XBRL Definitions -- wkbt-20111231_def XML 300K 14: EX-101.LAB XBRL Labels -- wkbt-20111231_lab XML 341K 15: EX-101.PRE XBRL Presentations -- wkbt-20111231_pre XML 348K 11: EX-101.SCH XBRL Schema -- wkbt-20111231 XSD 60K 17: ZIP XBRL Zipped Folder -- 0001144204-12-018721-xbrl Zip 56K
Exhibit 31.2
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002
I, Baolin Sun, certify that:
1. I have reviewed this annual report on Form 10-K of Weikang Bio-Technology Group Co., Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; |
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):
a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting. |
Dated: March 30, 2012 | By: | /s/ Baolin Sun |
Chief Financial Officer |
C:
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 3/30/12 | None on these Dates | ||
For Period end: | 12/31/11 | |||
List all Filings |